Delivery System– tag –
-
Evonik Invests Over $108 Million in Vancouver GMP Facility, Tripling Lipid-Based Drug Delivery Capacity
bionity.com Canada Overview Evonik announced an investment exceeding CAD 150 million (approximately USD 108 million) into its GMP manufacturing facility in Vancouver, Canada, more than tripling its production capacity for lipid-based dru... -
Evonik Invests $108M in Vancouver GMP Facility, Significantly Expanding Lipid-Based Drug Delivery Manufacturing Capacity
Contract Pharma USA Overview Evonik has announced a significant investment of $108 million into its GMP formulation manufacturing facility in Vancouver, Canada, dedicated to lipid-based drug delivery. This substantial capital injection a... -
Engineering Approaches to Modify Mesenchymal Stromal Cell (MSC) Immunomodulatory Functions: Advancing Tissue Regeneration and Clinical Application via iPSC-Derived MSCs, Cell Pre-treatment, and EV Therapeutics
PMC International Overview Engineering approaches to modify mesenchymal stromal cell (MSC) immunomodulatory functions are crucial for tissue regeneration and clinical applications. These strategies include cell pre-treatment and genetic ... -
Liv Hospital Advances iPSC Reprogramming, Sets Sights on Scalable Production for Regenerative Medicine
Liv Hospital Turkey Overview Liv Hospital's latest research details critical optimizations in induced pluripotent stem cell (iPSC) reprogramming, emphasizing advanced gene delivery systems and optimal vector selection for efficient and s... -
Eli Lilly Acquires Kelonia and Orna Therapeutics as Investment in In Vivo Cell Therapies Surges, Aiming to Reduce Treatment Burden and Manufacturing Costs
DCAT Value Chain Insights USA Overview In vivo cell therapies, where the patient's body becomes the manufacturing site for cells like CAR T cells, are attracting substantial biopharmaceutical investment due to their potential to reduce t... -
Novo Nordisk Partners with India’s Shantha Biologics for Global Cartridge Fill-Finish Services
The SouthFirst India Overview Novo Nordisk has signed an outsourcing agreement with Hyderabad-based Shantha Biologics for cartridge fill-finish manufacturing services for its global supply chain. This strategic collaboration signifies Sh... -
BioProcess International Advocates for Building a Distributed Model for Future Autologous Cell Therapy Manufacturing
BioProcess International Netherlands Overview BioProcess International and IB Communications held a video roundtable proposing the construction of a distributed manufacturing model for the future of autologous cell therapy biomanufacturi...
1